Andrew Guggenhime, President and CFO: Vaxcyte PCVX Sell · Filed 23/11/22

Trade details

Type: Insider sale
Amount: $402,621.12
Shares · price: 7,876 sh · $51.12 a share
Held after: 79,598 sh
Stock: Vaxcyte PCVX
Person: Andrew GuggenhimePresident and CFO
Trade date: 23/11/20
Filed: 23/11/22
Days to filing: 2 days

Sold 9.0% of holdings

Share of holding sold: 9.0%

Vaxcyte trades, last 26 weeks

What else happened in Vaxcyte around then

Filed or reported within 30 days of the trade day · 23/10/21~23/12/20

Andrew Guggenhime's recent trades

Andrew GuggenhimePresident and CFO
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 plan
Vaxcyte
PCVX
$539.9K
10,000 sh
$539.9K
Filed 08/03
Traded 08/03
Andrew GuggenhimePresident and CFO
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 plan
Vaxcyte
PCVX
$577.6K
10,000 sh
$577.6K
Filed 07/06
Traded 07/06
Andrew GuggenhimePresident and CFO
Sell10b5-1 planVaxcyte
Sell10b5-1 plan
Vaxcyte
PCVX
$530K
10,000 sh
$530K
Filed 06/18
Traded 06/18
Andrew GuggenhimePresident and CFO
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 plan
Vaxcyte
PCVX
$530K
10,000 sh
$530K
Filed 06/18
Traded 06/18
Andrew GuggenhimePresident and CFO
Sell10b5-1 planVaxcyte
Sell10b5-1 plan
Vaxcyte
PCVX
$517.1K
6,182 sh
$517.1K
Filed 25/02/19
Traded 25/02/18

Andrew Guggenhime, CFO — sold $402.6K of Vaxcyte PCVX · 9.0% of holdings · 10b5-1 plan | Whalegun